Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin for Glucose Fluctuation in Type 1 Diabetes
NCT02307695Phase 4Unknown
- Sponsor
- Nanjing Medical University
- Start
- Nov 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in type 1 diabetes mellitus (T1D), sponsored by Nanjing Medical University. Status: unknown.
02
Drugs
saxagliptin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02307695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02307695.